Purpose of trial: The purpose of this clinical trial is:
- To determine any side effects of these combined drugs and test the safety of the treatment
- To ascertain whether the treatment can prolong the lives of mesothelioma patients
- To assess whether the combinations of these drugs alters the size of the tumour and for how long
- To assess whether patients feel any improvement whilst receiving the treatment.
Eligibility: To be eligible to join this clinical trial you must:
- Have been diagnosed with mesothelioma that can be treated through chemotherapy
- Have received no previous chemotherapy treatment for mesothelioma
- Have one or more measurable lesions
- Have a reasonable performance status
Click Here To Return To The
Mesothelioma Clinical Trial Abstracts Overview Page.